Latest news with #RedLightHolland
Yahoo
26-07-2025
- Business
- Yahoo
Red Light Holland teams up with Arch Public for Bitcoin Strategy
Red Light Holland teams up with Arch Public for Bitcoin Strategy originally appeared on TheStreet. Red Light Holland, a Canadian company that produces functional mushrooms and psilocybin truffles, has selected Arch Public Inc. as its primary partner to assist in managing its Bitcoin investment strategy. The decision comes after Red Light Holland announced it will invest up to C$2 million in Bitcoin and other digital assets. As part of this goal, the business has already put C$210,000 into a Bitcoin ETF. On July 15, the firm took on Scott Melker, a renowned crypto Key Opinion Leader, as its Bitcoin Light Holland added Bitcoin to its balance sheet since it was having trouble with its banking because of its work in the psychedelics industry. The firm viewed Bitcoin as a means to achieve financial independence after being debanked, despite operating a legal and functional mushroom farm. "So we were debanked as we were proceeding with, ironically, just a regular mushroom farm, not even the psychedelic mushroom farms," said Todd Shapiro, CEO of Red Light Holland Corp, in an interview. Arch Public will facilitate the buying of Bitcoin through automated trading strategies (algorithms). Their approach involves buying Bitcoin on dips and protecting the investment from loss, as all assets won't be sold for less than the original cost. It supports dollar-cost averaging strategies, adjustable monthly allocations, and flexible plans to streamline the creation of an innovative, behavior-based Bitcoin portfolio. "We are excited to partner with Red Light Holland to support their Bitcoin Balance Sheet strategy. Our algorithms remove emotional biases, allowing companies like Red Light Holland to accumulate intelligently, safely, and reconcile instantly while not being distracted from their core day-to-day business," said Tillman Holloway, Co-founder and CEO of Arch Public. The partnership shows that Red Light Holland wants to combine decentralized finance with its larger goal of making new things in wellness and psychedelics. Red Light Holland teams up with Arch Public for Bitcoin Strategy first appeared on TheStreet on Jul 25, 2025 This story was originally reported by TheStreet on Jul 25, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Globe and Mail
25-07-2025
- Business
- Globe and Mail
Red Light Holland Selects Arch Public for Bitcoin Purchases on Recommendation from Advisor Scott Melker
Toronto, Ontario--(Newsfile Corp. - July 25, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws today announced its selection of Arch Public Inc. as a key partner for executing Bitcoin purchases. This decision follows the Company's recent Bitcoin balance sheet strategy announcement on July 15, 2025, and comes on the recommendation of Lead Cryptocurrency Advisor Scott Melker. Arch Public's algorithmic trading platform will assist Red Light Holland in strategically accumulating Bitcoin, leveraging automated strategies to optimize entry points and enhance treasury diversification. Arch Public Inc. is an innovative algorithmic crypto trading platform specializing in Bitcoin and other cryptocurrencies, designed to deliver returns through emotion-free, data-driven trading. Their Bitcoin-specific services include strategic accumulation during market dips, arbitrage algorithms that ensure sales only above cost basis for principal protection, and customizable strategies for asset growth and yield generation. With back tested results demonstrating strong performance, Arch Public aligns perfectly with Red Light Holland's goals of financial resilience and innovation in decentralized finance. "On the advice of our trusted advisor Scott Melker, we've chosen Arch Public to streamline our Bitcoin acquisitions," said Todd Shapiro, CEO of Red Light Holland. "Their platform's focus on smart, automated accumulation and risk management will help us with our Bitcoin balance sheet strategy, aimed at minimizing volatility exposure. This partnership is a natural extension of our commitment to embracing cryptocurrency as a hedge against traditional market uncertainties, empowering our continued goals of growth in the psychedelics sector." Scott Melker, lead Cryptocurrency Advisor to Red Light Holland, added: "Arch Public stands out for its sophisticated algorithms that aim to outperform simple buy-and-hold strategies. I recommended them to Red Light Holland because their tools provide the precision and efficiency needed for corporate Bitcoin integration, focused on long-term value creation." Tillman Holloway, Co-founder and CEO of Arch Public, commented: "We are excited to partner with Red Light Holland to support their Bitcoin Balance Sheet strategy. Our algorithms remove emotional biases, allowing companies like Red Light Holland to accumulate intelligently, safely, and reconcile instantly while not being distracted from their core day-to-day business. As our platform grows, we are gaining lots of attention from both retail customers and larger publicly traded companies, like Red Light Holland, and we are pleased to provide a service that helps." This collaboration underscores Red Light Holland's proactive approach to integrating blockchain and cryptocurrency into its operations, further supporting themes of decentralization and personal sovereignty in both financial and wellness domains. As previously announced, Red Light Holland is allocating up to C$2 million to Bitcoin and related assets. Key elements of the strategy include strategic investments up to C$250,000 per tranche, including an initial tranche on June 23, 2025, in which the Company invested C$210,000 in a Bitcoin ETF. For more information about Arch Public, visit About Red Light Holland Corp. Red Light Holland Corp. is an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe. The Company also offers a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws. Red Light Holland is dedicated to responsible adult-use psychedelics, fostering education, innovation, and accessibility in the sector. CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company's performance, business objectives and milestones and the anticipated timing thereof, and costs in connection with, the execution or achievement of such objectives and milestones, including its plans to relating to the Bitcoin strategy and to work with Scott Melker and Arch Public and the stated goals of this consultant relationship. Forward-looking information in this press release are based on certain assumptions and expected future events, namely: the Company's ability to carryout its plans relating to the Bitcoin strategy and to work with Scott Melker, Arch Public and achieve the stated goals of this consultant relationship. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company's inability to carryout its plans relating to the Bitcoin strategy and to work with Scott Melker, Arch Public and achieve the stated goals of this consultant relationship. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law.
Yahoo
16-07-2025
- Business
- Yahoo
Debanking drives psychedelics firm to tap Scott Melker to drive Bitcoin strategy
Debanking drives psychedelics firm to tap Scott Melker to drive Bitcoin strategy originally appeared on TheStreet. Red Light Holland Corp. (CSE: TRIP), an Ontario-based psychedelics company, announced on July 15 that it has adopted a Bitcoin balance sheet strategy. The company is engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, in addition to psilocybin truffles in the legal, recreational market within the Netherlands. Scott Melker is the host of The Street Roundtable and The Wolf of All Streets podcasts, joined Red Light Holland as its senior advisor and crypto czar on July said: "Red Light Holland's pivot to Bitcoin after banking challenges is pure grit and vision. This isn't just about smart investments; it's about building a decentralized future where people hold the power. I'm fired up to lead their Bitcoin strategy and help make Red Light Holland a beacon in both psychedelics and crypto." The psychedelics company said its decision to embrace Bitcoin is informed by its past experiences of having faced challenges with traditional banking, including being debanked by a Tier 1 bank. Red Light Holland CEO Todd Shapiro said: "Psilocybin users and Bitcoin holders are visionaries who crave mental and financial freedom. After navigating debanking by a Tier 1 bank, we embraced Bitcoin as our store of value, proving our resilience." Red Light Holland is going to allocate up to around $1.5 million (CAD 2 million) to Bitcoin and related assets. It is exploring the cryptocurrency as a "decentralized solution" to bolster financial resilience. The company's new balance sheet strategy includes investing up to around $182,000 (CAD 250,000) per tranche. Its initial investment of around $153,000 (CAD 210,000) in a Bitcoin ETF on June 23 has already delivered an impressive return, it said. Bitcoin hit a record high of $123,091.61 on July 14 and is undergoing a correction phase. As per Kraken's price feed, BTC was trading at $116,820.36 at press time. Debanking drives psychedelics firm to tap Scott Melker to drive Bitcoin strategy first appeared on TheStreet on Jul 15, 2025 This story was originally reported by TheStreet on Jul 15, 2025, where it first appeared. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
21-05-2025
- Business
- Yahoo
Red Light Holland's FDA-Compliant, DEA-Registered Partner Irvine Labs Granted United States Controlled Substances Import Permit for the Company's Raw Psilocybin Truffles
Red Light Holland is moving forward with the import of 3 kg (3000 grams) of raw psilocybin truffles from the Company's farm in The Netherlands to the United States, via a Controlled Substances Import Permit. Following this major milestone approval, Red Light Holland will ship their carefully packaged raw psilocybin truffles to California based, Irvine Labs, for development of extended shelf-life microdosing capsules. Toronto, Ontario--(Newsfile Corp. - May 21, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growth, and sale of functional mushrooms and mushroom home grow kits in North America and Europe, as well as a premium brand of psilocybin truffles in the legal, recreational market within the Netherlands, in compliance with all applicable laws is excited to announce that its research and development partner, Irvine Labs Inc. ("Irvine Labs"), an FDA-compliant and DEA-registered facility in California, United States has successfully received its Controlled Substances Import Permit for psilocybin raw materials (truffles) from the Company's farm in Horst, the Netherlands, following the 2025 psilocybin DEA quotas announced in April. With both the DEA quota and import permit now secured, Irvine Labs and Red Light Holland will proceed with the shipment of 3 kg of raw psilocybin material from the company's farm in the Netherlands in the coming weeks. Red Light Holland's partner, Irvine Labs is licensed for prescription and over-the-counter (OTC) drug manufacturing by the California Department of Public Health (CDPH) and is a DEA Schedule 1 Bulk drug cultivator, manufacturer, importer and exporter; including psilocybin, psilocin, marijuana, THC, extracts, DET, DMT, LSD, peyote and mescaline. The Companies are thrilled to continue their advancement in R&D including working diligently on the preservation of psilocybin from naturally derived compounds during product development and manufacturing. Through Red Light Holland's partnership with Irvine Labs and the implementation of proprietary preservation technology, Red Light Holland aims to develop precise dehydration, manufacturing and storage protocols that maintain the integrity of natural compounds while significantly extending product shelf life. Combined with research into advanced packaging solutions, these innovations represent a comprehensive approach to ensuring product stability and quality throughout the supply chain. "We are thrilled to announce this major milestone in our partnership with Irvine Labs, as they have now received their import permit for 3 kg of psilocybin raw materials," said Todd Shapiro, CEO and Director of Red Light Holland. "This advancement comes at a significant time as we've seen growing institutional support for psilocybin research, including from the new U.S. Surgeon General and the Department of Veterans Affairs, which we applaud. With the Controlled Substances Import Permit secured, we can now ship our psilocybin raw materials from our Netherlands farm to Irvine's California Lab to begin development of extended shelf-life microdosing capsules. This is another critical step in our mission: from underground to mainstream, and as a Company we are very proud of our overall progress and focus on standardization of naturally occurring psilocybin as our R&D continues with the overall goal of access and making a positive impact." Shaun Land, President of Irvine Labs, added, "Receiving the Controlled Substances Import Permit represents the final regulatory hurdle in our collaboration with Red Light Holland, at this stage. We are now ready to receive the 3 kg of raw materials from the Netherlands and begin our work. We have extensive experience working with naturally derived pharmaceutical ingredients and are excited to support Red Light Holland's microdosing program with our expertise in manufacturing and compliance, aiming to extend these innovative products stability and shelf life." Red Light and Irvine Labs combined goal is to develop a commercialized and standardized product from the Company's psilocybin truffles farm grown truffles that can be legally exported to emerging markets and used in government-funded pilot programs and clinical trials within the United States. About Irvine Labs Irvine Labs was established in 1997. Since 2013, Irvine Labs has had a significant investment in medical research and development through its Pharmaceutical Biotechnology Division with a focus on natural medicines, including cannabis, cannabinoids, psilocybin, herbs and other sources of natural medicines. Irvine Labs is licensed for Prescription and Over-the-Counter (OTC) drug manufacturing by the California Department of Public Health (CDPH). Irvine Labs is a DEA Schedule 1 Bulk drug manufacturer, importer and exporter (including marijuana, THC, extracts, psilocybin, psilocin, DET, DMT, LSD, Peyote and Mescaline), and Schedule 1-5 testing lab. About Red Light Holland Red Light Holland is an Ontario-based corporation engaged in the production, growth and sale of functional mushrooms and mushroom home grow kits in North America and Europe, and a premium brand of psilocybin truffles to the legal, recreational market within the Netherlands, in compliance with all applicable laws. For additional information on the Company: Todd Shapiro Chief Executive Officer & Director Tel: 647-643-TRIP (8747) Email: todd@ Website: Forward-Looking Statements and Cautionary Note CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS This press release contains "forward-looking information" within the meaning of applicable Canadian securities legislation. These statements relate to future events or future performance. The use of any of the words "could", "intend", "expect", "believe", "will", "projected", "estimated" and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the Company's current belief or assumptions as to the outcome and timing of such future events. The forward-looking information and forward-looking statements contained herein include, but are not limited to, statements regarding: the Company's performance, business objectives and milestones and the anticipated timing thereof, and costs in connection with, the execution or achievement of such objectives and milestones, including its plans to continue seeking legal opportunities to increase responsible access to natural psilocybin around the world and Irvine lab's development of the Company's psilocybin; the Company and the Company's partners to maintain its stated licenses and obtain all necessary additional licenses and regulatory approval required for the Company to carry out its plans as described; the expectations with respect to the Company's planned psilocybin import following Irvine Labs' successful receipt of its 2025 psilocybin DEA quota and pending import permit approval; the Company's continued commitment towards ensuring legal, responsible access to Red Light's standardized natural psilocybin products; the Company's commitment to making further announcements with respect to its overall R&D project, including its partnership with Irvine Labs Inc. and the research project to develop a process for the commercial manufacture of microdosing capsules derived from the Company's psilocybin truffles; the Company proving out potential therapeutic benefits of Psilocybin; the Company receiving important insights from naturally occurring psilocybin truffles; the Company's ability to extract and expand access to psilocybin products; the Company's ability to successfully land the 3K shipment in the United States of America, the Company's ability to control the risk that the Controlled Substances Import Permit could become null and void and/or reversed; the Company's goals to standardize and sell advanced microdosing products to emerging markets or the United States for clinical trials or government funded programs; and the Company's ability to scalable production of high-quality, and approved microdoing capsules with extended shelf life via Irvine Labs ability to export their manufactured products from the United States to emerging markets, or sell to government funded pilot programs or clinical trials in the United States or around the world. Forward-Looking information in this press release are based on certain assumptions and expected future events, namely: the Company's ability to maintain or exceed its current performance, and carry out its business objectives and milestones and under the anticipated timing and costs in connection with, the execution or achievement of such objectives and milestones; the Company and the Company's partners' abilities, including Irvine Labs to maintain its stated licenses and obtain all necessary additional licenses and regulatory approval required for the Company to carry out its plans as described; the Company's ability to realize its plans for its planned psilocybin imports following Irvine Labs' successful receipt of its 2025 psilocybin DEA quota and pending import permit approval; the Company's ability for its continued commitment towards ensuring legal, responsible access to Red Light's standardized natural psilocybin products; the Company's ability to maintain its commitment to making further announcements with respect to its overall R&D project, including its partnership with Irvine Labs and their research project to develop a process for the commercial manufacture of natural-source microdoing capsules derived from the Company's psilocybin truffles; the Company proving out potential therapeutic benefits of Psilocybin; the Company receiving important insights from naturally occurring psilocybin truffles; the ability to extract and expand access to psilocybin products; the Company's ability to successfully land the shipment in the United States of America, the Company's goals to standardize and sell advanced microdosing products to emerging markets or the United States for clinical trials or government funded programs; the Company's ability to control the risk that the Controlled Substances Import Permit could become null and void and/or reversed; and the Company's ability to have scalable production of high-quality, microdosing capsules with extended shelf life for Global Distribution and The Company's ability to import their products into the United States and eventually the Companys ability to export their manufactured products from the United States to emerging markets, or sell to government funded pilot programs or clinical trials in the USA or around the world. These statements involve known and unknown risks, uncertainties and other factors, which may cause actual results, performance or achievements to differ materially from those expressed or implied by such statements, including but not limited to: the Company's inability to maintain or exceed its current performance, and carry out its business objectives and milestones and under the anticipated timing and costs in connection with, the execution or achievement of such objectives and milestones; the Company and the Company's partners' inabilities, including Irvine Labs, to maintain its stated licenses and obtain all necessary additional licenses and regulatory approval required for the Company to carry out its plans as described; the Company's inability to realize upon its plans for its planned psilocybin import despite Irvine Labs' successful receipt of its 2025 psilocybin DEA quota; delays or issues with the import permit process; the Company's inability to maintain its commitment towards ensuring legal, responsible access to Red Light's standardized natural psilocybin products; the Company's inability to maintain its commitment to making further announcements with respect to its overall R&D project, including its partnership with Irvine Labs; and The Company's ability to expand and extract access to psilocybin products. The Company cannot make medical claims and is purely in a R&D phase with its partners Irvine Labs Inc. Readers are further cautioned not to place undue reliance on forward-looking statements, as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Such information, although considered reasonable by management at the time of preparation, may prove to be incorrect and actual results may differ materially from those anticipated. Forward-Looking statements contained in this press release are expressly qualified by this cautionary statement and reflect the Company's expectations as of the date hereof and are subject to change thereafter. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, estimates or opinions, future events or results or otherwise or to explain any material difference between subsequent actual events and such forward-looking information, except as required by applicable law. To view the source version of this press release, please visit Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-05-2025
- Business
- Yahoo
Red Light Holland Announces Happy Caps 2kg "Mega Block" Mushroom Home Grow Kits Are Now Available in Costco Stores Across Canada
Toronto, Ontario--(Newsfile Corp. - May 13, 2025) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTCQB: TRUFF) ("Red Light Holland" or the "Company"), a leader in functional mushrooms and home grow kits across North America and Europe, is pleased to announce that its wholly owned subsidiary, 4316747 Nova Scotia Limited o/a Happy Caps Mushroom Farms ("Happy Caps"), has officially re-stocked its Mushroom Home Grow Kits in Costco Canada stores nationwide, now available in the majority of select Costo Canada locations from coast to coast. This milestone follows Costco Canada's recent Informal Projection Letter (IPL), outlining a major order of 20,160 units of Happy Caps' newly designed 2kg "Mega Block" Mushroom Home Grow Kits, featuring Shiitake, Lion's Mane, and Oyster varieties. The 20,160 kits were delivered recently and are available, this week, across the country in time for the Victoria Day weekend. To view an enhanced version of this graphic, please visit: "We're thrilled to see Happy Caps kits on Costco shelves nationwide," said Todd Shapiro, CEO and Director of Red Light Holland. "Costco's expanded commitment demonstrates strong national demand for our grow-your-own mushroom kits. This is more than just a retail win, it's a meaningful moment for our Happy Caps' brand growth with focus on the mushroom movement." In addition to its partnership with Costco Canada, Happy Caps continues to explore opportunities with major retailers across North America. With this new Costco Canada launch, Happy Caps products now have seasonal presence in over 430 retail stores across North America. For more information about Happy Caps and its range of mushroom home grow kits, and the Company's newly launched Functional Mushroom Gummies please visit About Happy Caps Mushroom Farm Happy Caps is an urban gourmet mushroom farm specializing in quality 'grow your own mushroom kits' and Functional Mushroom Gummies. About Red Light HollandRed Light Holland is an Ontario-based company focused on the production, growth, and sale of functional mushrooms and mushroom grow kits across North America and Europe. The company also offers premium psilocybin truffles in the legal recreational market in the Netherlands. For additional information on the Company:Todd ShapiroChief Executive Officer & DirectorTel: 647-643-TRIP (8747)Email: todd@ Neither the Canadian Securities Exchange nor its Market Regulator (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. Cautionary Statement Regarding Forward-Looking Statements This press release contains certain "forward-looking information" within the meaning of applicable Canadian securities legislation. Such forward-looking information and forward-looking statements are not representative of historical facts or information or current condition, but instead represent only the Company's beliefs regarding future events, plans or objectives, many of which, by their nature, are inherently uncertain and outside of the Company's control. Often, but not always, forward-looking statements and information can be identified by the use of words such as "plans", "expects" or "does not expect", "is expected", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or state that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved. Forward-Looking information involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the Company or its respective subsidiaries to be materially different from any future results, performance or achievements expressed or implied by the forward-looking information contained in this news release. Examples of such information include statements with respect to: the stated plans, goals, and benefits of the partnership with Costco Canada, including the products and mushroom varieties to be offered for sale, the Costco Canada locations which the Company's products will be available for purchase, the amount of locations where Happy Caps Mushroom home Grow kits are located; and the timelines thereof; the stated benefits of the Company's Happy Caps Mushroom Home Grow Kits; the Company's continued exploration of partnerships with major retailers across North America; and the Company's stated number of retail locations where the products are seasonally, its business plans and goals. Forward-Looking information in this news release are based on certain assumptions and expected future events, namely: continued approval of the Company's activities by the relevant governmental and/or regulatory authorities; the Company's ability to carry out its stated plans, goals, and benefits of the partnership with Costco Canada under the stated timelines; the Company's ability to realize upon the stated benefits of the Company's Happy Caps Mushroom Home Grow Kits; the Company's ability to continue its exploration of partnerships with major retailers across North America; and the Company's ability to carry out its stated business plans and goals. Risks, uncertainties and other factors involved with forward-looking information could cause actual events, results, performance, prospects and opportunities to differ materially from those expressed or implied by such forward-looking information, the Company's inability to obtain continued approval of the Company's activities by the relevant governmental and/or regulatory authorities; the Company's inability to carry out its stated plans, goals, and benefits of the partnership with Costco Canada under the stated timelines; the Company's inability to realize upon the stated benefits of the Company's Happy Caps Mushroom Home Grow Kits; the Company's inability to continue its exploration of partnerships with major retailers across North America; the Company's inability to maintain the stated seasonal locations and their repeat orders and business; and the Company's inability to carry out its stated business plans and goals. Although the Company believes that the assumptions and factors used in preparing, and the expectations contained in, the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurance or guarantee can be given that such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and the Company does not undertake to update any forward-looking information and/or forward-looking statements that are contained or referenced herein, except in accordance with applicable securities laws. To view the source version of this press release, please visit Sign in to access your portfolio
